$PRPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ProPhase Labs, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ProPhase Labs, Inc.. Get notifications about new insider transactions in ProPhase Labs, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | PRPH | ProPhase Labs, Inc ... | Hirsch Warren | Director | Option Exercise | A | 5.28 | 50,000 | 264,000 | 50,000 | |
| Jun 10 2021 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Option Exercise | A | 5.28 | 100,000 | 528,000 | 100,000 | |
| May 10 2021 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 60,000 | 0 | 100,000 | 40 K to 100 K (+150.00 %) |
| May 10 2021 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 120,000 | 0 | 2,299,528 | 2.4 M to 2.3 M (-4.96 %) |
| Sep 11 2020 | PRPH | ProPhase Labs, Inc ... | Hirsch Warren | Director | Option Exercise | A | 2.83 | 50,000 | 141,500 | 50,000 | |
| Sep 11 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Option Exercise | A | 2.83 | 100,000 | 283,000 | 100,000 | |
| Sep 11 2020 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Option Exercise | A | 2.83 | 50,000 | 141,500 | 50,000 | |
| Aug 18 2020 | PRPH | ProPhase Labs, Inc ... | Brady Monica L. | Chief Financial Off ... | Option Exercise | A | 2.64 | 150,000 | 396,000 | 150,000 | |
| Aug 17 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Sell | S | 2.75 | 50,000 | 137,500 | 2,419,528 | 2.5 M to 2.4 M (-2.02 %) |
| Aug 17 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Buy | P | 2.75 | 50,000 | 137,500 | 273,840 | 223.8 K to 273.8 K (+22.34 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 28,600 | 0 | 40,000 | 11.4 K to 40 K (+250.88 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 25,550 | 0 | 40,000 | 14.5 K to 40 K (+176.82 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 54,150 | 0 | 2,469,528 | 2.5 M to 2.5 M (-2.15 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 28,600 | 0 | 40,000 | 11.4 K to 40 K (+250.88 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 25,550 | 0 | 40,000 | 14.5 K to 40 K (+176.82 %) |
| Jul 13 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Gift | G | 0.00 | 54,150 | 0 | 2,469,528 | 2.5 M to 2.5 M (-2.15 %) |
| Jul 02 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 1.43 | 7,878 | 11,266 | 223,840 | 216 K to 223.8 K (+3.65 %) |
| Jul 02 2020 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Grant | A | 1.43 | 4,727 | 6,760 | 30,241 | 25.5 K to 30.2 K (+18.53 %) |
| Apr 02 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 1.85 | 6,068 | 11,226 | 215,962 | 209.9 K to 216 K (+2.89 %) |
| Apr 02 2020 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Grant | A | 1.85 | 3,641 | 6,736 | 25,514 | 21.9 K to 25.5 K (+16.65 %) |
| Mar 27 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Buy | P | 1.75 | 100,000 | 175,000 | 209,894 | 109.9 K to 209.9 K (+91.00 %) |
| Mar 27 2020 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Sell | S | 1.75 | 100,000 | 175,000 | 2,549,528 | 2.6 M to 2.5 M (-3.77 %) |
| Jan 03 2020 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 2.02 | 5,564 | 11,239 | 109,894 | 104.3 K to 109.9 K (+5.33 %) |
| Jan 03 2020 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Grant | A | 2.02 | 2,782 | 5,620 | 21,873 | 19.1 K to 21.9 K (+14.57 %) |
| Jan 03 2020 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Grant | A | 2.02 | 2,782 | 5,620 | 21,873 | 19.1 K to 21.9 K (+14.57 %) |
| Nov 22 2019 | PRPH | ProPhase Labs, Inc ... | Brady Monica L. | Chief Financial Off ... | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
| Oct 03 2019 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 1.96 | 5,740 | 11,250 | 104,330 | 98.6 K to 104.3 K (+5.82 %) |
| Oct 03 2019 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Buy | P | 1.96 | 2,870 | 5,625 | 19,091 | 16.2 K to 19.1 K (+17.69 %) |
| Aug 16 2019 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 2.38 | 4,727 | 11,250 | 98,590 | 93.9 K to 98.6 K (+5.04 %) |
| Aug 16 2019 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Buy | P | 2.05 | 2,500 | 5,125 | 16,221 | 13.7 K to 16.2 K (+18.22 %) |
| Aug 16 2019 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Buy | P | 2.05 | 6,000 | 12,300 | 13,721 | 7.7 K to 13.7 K (+77.71 %) |
| Apr 04 2019 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 3.15 | 3,571 | 11,249 | 93,863 | 90.3 K to 93.9 K (+3.95 %) |
| Jan 15 2019 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 3.14 | 3,583 | 11,251 | 90,292 | 86.7 K to 90.3 K (+4.13 %) |
| Dec 17 2018 | PRPH | ProPhase Labs, Inc ... | Brady Monica L. | Chief Accounting Of ... | Option Exercise | A | 3.18 | 50,000 | 159,000 | 50,000 | |
| Oct 02 2018 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 3.01 | 3,737 | 11,248 | 86,709 | 83 K to 86.7 K (+4.50 %) |
| Oct 02 2018 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 3.01 | 3,737 | 11,248 | 318,282 | 314.5 K to 318.3 K (+1.19 %) |
| Jul 23 2018 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 3.01 | 3,737 | 11,248 | 82,972 | 79.2 K to 83 K (+4.72 %) |
| Jul 23 2018 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 3.01 | 3,737 | 11,248 | 314,545 | 310.8 K to 314.5 K (+1.20 %) |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Option Exercise | M | 2.00 | 150,000 | 300,000 | 450,000 | |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Option Exercise | M | 1.65 | 100,000 | 165,000 | 0 | |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Payment of Exercise | F | 5.45 | 55,046 | 300,001 | 2,649,528 | 2.7 M to 2.6 M (-2.04 %) |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Buy | M | 2.00 | 150,000 | 300,000 | 2,704,574 | 2.6 M to 2.7 M (+5.87 %) |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Payment of Exercise | F | 5.45 | 30,275 | 164,999 | 2,554,574 | 2.6 M to 2.6 M (-1.17 %) |
| May 17 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Buy | M | 1.65 | 100,000 | 165,000 | 2,584,849 | 2.5 M to 2.6 M (+4.02 %) |
| Feb 26 2018 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Option Exercise | A | 3.00 | 2,300,000 | 6,900,000 | 2,300,000 | |
| Dec 26 2017 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Sell | S | 2.30 | 424,789 | 977,015 | 2,484,849 | 2.9 M to 2.5 M (-14.60 %) |
| Dec 18 2017 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Option Exercise | M | 1.00 | 600,000 | 600,000 | 0 | |
| Dec 18 2017 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Buy | M | 1.00 | 600,000 | 600,000 | 2,909,638 | 2.3 M to 2.9 M (+25.98 %) |
| Oct 02 2017 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Sell | S | 2.30 | 1,695,305 | 3,899,202 | 627,322 | 2.3 M to 627.3 K (-72.99 %) |
| Oct 02 2017 | PRPH | ProPhase Labs, Inc ... | Barr Jason Michael | Director | Sell | S | 2.30 | 4,379 | 10,072 | 7,721 | 12.1 K to 7.7 K (-36.19 %) |
| Oct 02 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Sell | S | 2.30 | 358,621 | 824,828 | 132,703 | 491.3 K to 132.7 K (-72.99 %) |
| Oct 02 2017 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & CHAIRMAN | Sell | S | 2.30 | 364,950 | 839,385 | 2,309,638 | 2.7 M to 2.3 M (-13.65 %) |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Option Exercise | M | 1.39 | 40,000 | 55,600 | 0 | |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Option Exercise | M | 1.65 | 120,000 | 198,000 | 0 | |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Option Exercise | M | 1.00 | 200,000 | 200,000 | 0 | |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Buy | M | 1.39 | 40,000 | 55,600 | 491,324 | 451.3 K to 491.3 K (+8.86 %) |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Buy | M | 1.65 | 120,000 | 198,000 | 451,324 | 331.3 K to 451.3 K (+36.22 %) |
| Sep 15 2017 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Buy | M | 1.00 | 200,000 | 200,000 | 331,324 | 131.3 K to 331.3 K (+152.30 %) |
| Apr 28 2017 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Option Exercise | A | 2.00 | 600,000 | 1,200,000 | 600,000 | |
| Nov 30 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.48 | 948 | 1,403 | 881,980 | 881 K to 882 K (+0.11 %) |
| Nov 30 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.55 | 13,300 | 20,615 | 881,032 | 867.7 K to 881 K (+1.53 %) |
| Nov 25 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.30 | 17,252 | 22,428 | 867,732 | 850.5 K to 867.7 K (+2.03 %) |
| Nov 25 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.30 | 18,500 | 24,050 | 850,480 | 832 K to 850.5 K (+2.22 %) |
| Aug 19 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.61 | 145,309 | 233,947 | 832,180 | 686.9 K to 832.2 K (+21.16 %) |
| Aug 18 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.61 | 204,691 | 329,553 | 686,671 | 482 K to 686.7 K (+42.47 %) |
| Jun 08 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.40 | 71,471 | 100,059 | 481,980 | 410.5 K to 482 K (+17.41 %) |
| Jun 08 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 1.31 | 128,529 | 168,373 | 410,509 | 282 K to 410.5 K (+45.58 %) |
| Jun 05 2015 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | See Remarks | Buy | P | 1.30 | 200,000 | 260,000 | 2,674,588 | 2.5 M to 2.7 M (+8.08 %) |
| May 19 2015 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 1.35 | 199,504 | 269,330 | 2,474,588 | 2.3 M to 2.5 M (+8.77 %) |
| May 19 2015 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 1.34 | 10,496 | 14,065 | 2,275,084 | 2.3 M to 2.3 M (+0.46 %) |
| Jan 05 2015 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 3,147 | 0 | 31,829 | 28.7 K to 31.8 K (+10.97 %) |
| Jan 05 2015 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 6,295 | 0 | 281,980 | 275.7 K to 282 K (+2.28 %) |
| Jan 05 2015 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 6,295 | 0 | 79,235 | 72.9 K to 79.2 K (+8.63 %) |
| Jan 05 2015 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 6,295 | 0 | 79,235 | 72.9 K to 79.2 K (+8.63 %) |
| Jan 05 2015 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 6,295 | 0 | 310,808 | 304.5 K to 310.8 K (+2.07 %) |
| Dec 23 2014 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Grant | A | 0.00 | 100,000 | 0 | 2,264,588 | 2.2 M to 2.3 M (+4.62 %) |
| Dec 23 2014 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | COO/CFO | Option Exercise | A | 1.39 | 40,000 | 55,600 | 40,000 | |
| Nov 07 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.38 | 13,946 | 19,245 | 2,322,627 | 2.3 M to 2.3 M (+0.60 %) |
| Nov 07 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.37 | 7,500 | 10,275 | 2,308,681 | 2.3 M to 2.3 M (+0.33 %) |
| Nov 07 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.32 | 43,300 | 57,156 | 2,301,181 | 2.3 M to 2.3 M (+1.92 %) |
| Oct 10 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.30 | 169,975 | 221,120 | 2,257,881 | 2.1 M to 2.3 M (+8.14 %) |
| Oct 10 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.30 | 114,910 | 149,222 | 2,087,906 | 2 M to 2.1 M (+5.82 %) |
| Oct 06 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.40 | 16,900 | 23,621 | 1,972,996 | 2 M to 2 M (+0.86 %) |
| Sep 24 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.40 | 4,538 | 6,353 | 1,956,096 | 2 M to 2 M (+0.23 %) |
| Sep 24 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.38 | 16 | 22 | 1,951,558 | 2 M to 2 M (0.00 %) |
| Sep 24 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.40 | 44,042 | 61,659 | 1,951,542 | 1.9 M to 2 M (+2.31 %) |
| Sep 18 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.40 | 2,500 | 3,500 | 1,907,500 | 1.9 M to 1.9 M (+0.13 %) |
| Sep 18 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.41 | 10,000 | 14,100 | 1,905,000 | 1.9 M to 1.9 M (+0.53 %) |
| Sep 15 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.44 | 103,918 | 149,642 | 1,895,000 | 1.8 M to 1.9 M (+5.80 %) |
| Sep 15 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.58 | 3,409 | 5,386 | 1,791,082 | 1.8 M to 1.8 M (+0.19 %) |
| Sep 15 2014 | PRPH | ProPhase Labs, Inc ... | Leonard Braden Michael | 10% Owner | Buy | P | 1.53 | 14,613 | 22,358 | 1,787,673 | 1.8 M to 1.8 M (+0.82 %) |
| Jun 26 2014 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 1.58 | 155,480 | 245,658 | 2,164,588 | 2 M to 2.2 M (+7.74 %) |
| Jun 26 2014 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 1.56 | 286,150 | 446,394 | 2,009,108 | 1.7 M to 2 M (+16.61 %) |
| Jun 26 2014 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 1.51 | 58,370 | 88,139 | 1,722,958 | 1.7 M to 1.7 M (+3.51 %) |
| Dec 20 2013 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Option Exercise | A | 1.65 | 100,000 | 165,000 | 100,000 | |
| Dec 20 2013 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Grant | A | 0.00 | 50,000 | 0 | 1,664,588 | 1.6 M to 1.7 M (+3.10 %) |
| Dec 20 2013 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | COO / CFO | Option Exercise | A | 1.65 | 120,000 | 198,000 | 120,000 | |
| Jul 15 2013 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 2,745 | 0 | 28,682 | 25.9 K to 28.7 K (+10.58 %) |
| Jul 15 2013 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 2,745 | 0 | 304,513 | 301.8 K to 304.5 K (+0.91 %) |
| Jul 15 2013 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 2,745 | 0 | 72,940 | 70.2 K to 72.9 K (+3.91 %) |
| Jul 15 2013 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 2,745 | 0 | 72,940 | 70.2 K to 72.9 K (+3.91 %) |
| Jul 15 2013 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 5,490 | 0 | 275,685 | 270.2 K to 275.7 K (+2.03 %) |
| May 28 2013 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Buy | P | 1.65 | 20,000 | 33,000 | 70,195 | 50.2 K to 70.2 K (+39.84 %) |
| May 10 2013 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Buy | P | 1.60 | 1,304 | 2,086 | 180,000 | 178.7 K to 180 K (+0.73 %) |
| May 10 2013 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Buy | P | 1.60 | 8,696 | 13,914 | 178,696 | 170 K to 178.7 K (+5.12 %) |
| Nov 30 2012 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Buy | P | 1.55 | 834 | 1,293 | 25,937 | 25.1 K to 25.9 K (+3.32 %) |
| Nov 30 2012 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Buy | P | 1.60 | 102,700 | 164,320 | 150,000 | 47.3 K to 150 K (+217.12 %) |
| Nov 30 2012 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Buy | P | 1.42 | 47,300 | 67,166 | 47,300 | 0 to 47.3 K |
| Sep 06 2012 | PRPH | ProPhase Labs, Inc ... | QUIGLEY GUY J | 10% Owner | Option Exercise | S | 1.40 | 1 | 1 | 1 | |
| May 17 2012 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chariman | Buy | P | 1.05 | 103,402 | 108,572 | 1,614,588 | 1.5 M to 1.6 M (+6.84 %) |
| May 17 2012 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chariman | Buy | P | 0.98 | 141,388 | 138,560 | 1,511,186 | 1.4 M to 1.5 M (+10.32 %) |
| Jan 11 2012 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Grant | A | 0.00 | 10,757 | 0 | 131,324 | 120.6 K to 131.3 K (+8.92 %) |
| Dec 16 2011 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Grant | A | 0.00 | 33,603 | 0 | 120,567 | 87 K to 120.6 K (+38.64 %) |
| Dec 16 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Grant | A | 0.00 | 134,409 | 0 | 1,369,798 | 1.2 M to 1.4 M (+10.88 %) |
| Nov 18 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 0.90 | 19,192 | 17,254 | 1,235,389 | 1.2 M to 1.2 M (+1.58 %) |
| Nov 15 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Buy | P | 0.85 | 171,018 | 145,707 | 1,216,197 | 1 M to 1.2 M (+16.36 %) |
| Nov 15 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Buy | P | 0.87 | 100,000 | 86,500 | 301,768 | 201.8 K to 301.8 K (+49.56 %) |
| Oct 12 2011 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Financial Off ... | Grant | A | 0.00 | 15,665 | 0 | 86,964 | 71.3 K to 87 K (+21.97 %) |
| Oct 11 2011 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 5,640 | 0 | 25,103 | 19.5 K to 25.1 K (+28.98 %) |
| Oct 07 2011 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 11,280 | 0 | 50,195 | 38.9 K to 50.2 K (+28.99 %) |
| Oct 07 2011 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 11,280 | 0 | 290,195 | 278.9 K to 290.2 K (+4.04 %) |
| Oct 07 2011 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 11,280 | 0 | 70,195 | 58.9 K to 70.2 K (+19.15 %) |
| Oct 07 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 11,280 | 0 | 201,768 | 190.5 K to 201.8 K (+5.92 %) |
| Aug 25 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Buy | P | 0.85 | 100 | 85 | 190,488 | 190.4 K to 190.5 K (+0.05 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 5,460 | 0 | 19,463 | 14 K to 19.5 K (+38.99 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 10,925 | 0 | 278,915 | 268 K to 278.9 K (+4.08 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 10,925 | 0 | 38,915 | 28 K to 38.9 K (+39.03 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 10,925 | 0 | 58,915 | 48 K to 58.9 K (+22.77 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Operating Off ... | Grant | A | 0.00 | 15,170 | 0 | 71,299 | 56.1 K to 71.3 K (+27.03 %) |
| Jul 14 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 10,925 | 0 | 190,388 | 179.5 K to 190.4 K (+6.09 %) |
| Apr 25 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chaiman | Grant | A | 0.00 | 161,830 | 0 | 1,045,179 | 883.3 K to 1 M (+18.32 %) |
| Apr 25 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chaiman | Grant | A | 0.00 | 128,571 | 0 | 883,349 | 754.8 K to 883.3 K (+17.03 %) |
| Apr 25 2011 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chaiman | Grant | A | 0.00 | 133,928 | 0 | 754,778 | 620.9 K to 754.8 K (+21.57 %) |
| Apr 21 2011 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 3,620 | 0 | 14,003 | 10.4 K to 14 K (+34.86 %) |
| Apr 15 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 7,235 | 0 | 179,463 | 172.2 K to 179.5 K (+4.20 %) |
| Apr 15 2011 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 7,235 | 0 | 267,990 | 260.8 K to 268 K (+2.77 %) |
| Apr 13 2011 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Operating Off ... | Grant | A | 0.00 | 10,050 | 0 | 56,129 | 46.1 K to 56.1 K (+21.81 %) |
| Apr 13 2011 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 7,235 | 0 | 47,990 | 40.8 K to 48 K (+17.75 %) |
| Apr 13 2011 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 7,235 | 0 | 27,990 | 20.8 K to 28 K (+34.86 %) |
| Feb 02 2011 | PRPH | ProPhase Labs, Inc ... | Leventhal Mark S | Director | Grant | A | 0.00 | 7,175 | 0 | 260,755 | 253.6 K to 260.8 K (+2.83 %) |
| Feb 02 2011 | PRPH | ProPhase Labs, Inc ... | Frank Mark Shawn | Director | Grant | A | 0.00 | 7,175 | 0 | 20,755 | 13.6 K to 20.8 K (+52.84 %) |
| Jan 31 2011 | PRPH | ProPhase Labs, Inc ... | MCCUBBIN JAMES T | Director | Grant | A | 0.00 | 3,590 | 0 | 10,383 | 6.8 K to 10.4 K (+52.85 %) |
| Jan 31 2011 | PRPH | ProPhase Labs, Inc ... | Burnett Mark A. | Director | Grant | A | 0.00 | 7,175 | 0 | 172,228 | 165.1 K to 172.2 K (+4.35 %) |
| Jan 31 2011 | PRPH | ProPhase Labs, Inc ... | GLECKEL LOUIS MD | Director | Grant | A | 0.00 | 7,175 | 0 | 40,755 | 33.6 K to 40.8 K (+21.37 %) |
| Jan 31 2011 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Operating Off ... | Grant | A | 0.00 | 9,968 | 0 | 46,079 | 36.1 K to 46.1 K (+27.60 %) |
| Dec 30 2010 | PRPH | ProPhase Labs, Inc ... | QUIGLEY GUY J | 10% Owner | Sell | S | 1.11 | 1,000 | 1,110 | 2,441,559 | 2.4 M to 2.4 M (-0.04 %) |
| Dec 30 2010 | PRPH | ProPhase Labs, Inc ... | QUIGLEY GUY J | 10% Owner | Sell | S | 1.11 | 1,000 | 1,110 | 2,442,559 | 2.4 M to 2.4 M (-0.04 %) |
| Dec 30 2010 | PRPH | ProPhase Labs, Inc ... | QUIGLEY GUY J | 10% Owner | Sell | S | 1.10 | 3,000 | 3,300 | 2,443,559 | 2.4 M to 2.4 M (-0.12 %) |
| Dec 15 2010 | PRPH | ProPhase Labs, Inc ... | Karkus Ted William | CEO & Chairman | Option Exercise | A | 1.00 | 600,000 | 600,000 | 600,000 | |
| Dec 15 2010 | PRPH | ProPhase Labs, Inc ... | CUDDIHY ROBERT V JR | Chief Operating Off ... | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 |